If suspension of DR-TB therapy is considered, there should be discussion with the entire clinical team – including the patient and all physicians, nurses and health workers or TB treatment supporters involved in the patient’s care. If the clinical team decides together that treatment should be suspended, a clear plan should be prepared for approaching the patient and the family. This process usually requires personal interaction with patient and family, ideally including home visits, and may take several weeks. It is not recommended to suspend therapy before the patient understands and accepts the reasons to do so, agrees with a change in goals of care to optimizing quality of life and comfort, and accepts palliative care. It is crucial that care continues and that the patient not be abandoned.